ADHD Meds May Double Cardiovascular Event Risk in Kids
The use of psychostimulants in children and adolescents is associated with nearly twice the risk for a cardiovascular event compared with nonuse of the drugs, and the risk is even higher when the drugs are used for the treatment of attention-deficit/hyperactivity disorder (ADHD), new research suggests. However, some experts are questioning whether these findings are clinically meaningful.
“In this large nationwide cohort study, we found that stimulant treatment increased the risk of cardiovascular events both in the total national population and in a population-based sample of children and adolescents with ADHD,” investigators, led by Søren Dalsgaard, MD, PhD, of Aarhus University, in Denmark, write.
The study was published online June 23 in the Journal of Child and Adolescent Psychopharmacology.
The study was published online June 23 in the Journal of Child and Adolescent Psychopharmacology.
via Blogger http://bit.ly/1xyl14x
Recent Comments